Sanofi Bets Big On IgM ‘Super Antibodies’ In Potential $6bn Cancer and Immunology Deal

IGM Biosciences Is Leader In Novel Field

 
• By Andrew McConaghie
  
Sanofi
The IGM Bioscience alliance gives Sanofi a differentiated approach in a crowded field of next generation antibody platforms. • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip